Global Erdafitinib Tablets Supply, Demand and Key Producers, 2026-2032
The global Erdafitinib Tablets market size is expected to reach $ 523 million by 2032, rising at a market growth of 9.2% CAGR during the forecast period (2026-2032).
Erdafitinib is an oral, highly selective small?molecule pan?FGFR inhibitor that mainly targets fibroblast growth factor receptors FGFR1–4. It inhibits the activity of receptor tyrosine kinases and blocks downstream signal transduction, thereby suppressing tumor cell proliferation, differentiation and angiogenesis. As the world’s first approved FGFR?targeted drug for solid tumors, this agent is mainly indicated for advanced malignant tumors with FGFR genetic abnormalities, particularly for locally advanced or metastatic urothelial carcinoma after failure of platinum?based chemotherapy. It has important clinical value in the precision therapy of solid tumors such as bladder cancer and cholangiocarcinoma, providing a novel targeted therapeutic option for patients with FGFR?mutant tumors.n 2025, global Erdafitinib production reached approximately 42,000 units.
As the world’s first approved pan-FGFR inhibitor, Erdafitinib occupies a core position in the precision treatment of FGFR-mutant solid tumors. Its market pattern is characterized by dominance of the innovator drug, impact from generic drugs, and growth driven by medical insurance coverage and indication expansion. As a product of Johnson & Johnson, the drug has established a first-mover advantage owing to its significant efficacy in urothelial carcinoma, while indications are rapidly expanding to more FGFR-mutant cancers such as cholangiocarcinoma and lung cancer.
The domestic market was approved in early 2025; it has not yet been included in medical insurance, resulting in high prices and limited patient accessibility. Overseas generic versions (from Laos, Bangladesh) divert part of the demand at lower prices, intensifying market competition. Globally, Erdafitinib faces competition from other FGFR inhibitors including pemigatinib and infigratinib. Market competition is gradually shifting from single indications to multi-cancer applications and combination therapies.
In the future, with the advancement of medical insurance coverage, full launch of generic drugs, expanded indications, and clinical breakthroughs in combination with immunotherapy or anti-angiogenic therapy, the market for Erdafitinib will continue to expand. Meanwhile, the pricing system will become more rational and patient accessibility will be significantly improved.
This report studies the global Erdafitinib Tablets production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Erdafitinib Tablets and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Erdafitinib Tablets that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Erdafitinib Tablets total production and demand, 2021-2032, (Units)
Global Erdafitinib Tablets total production value, 2021-2032, (USD Million)
Global Erdafitinib Tablets production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Erdafitinib Tablets consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Erdafitinib Tablets domestic production, consumption, key domestic manufacturers and share
Global Erdafitinib Tablets production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Erdafitinib Tablets production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Erdafitinib Tablets production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Erdafitinib Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Janssen Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Erdafitinib Tablets market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Erdafitinib Tablets Market, By Region:
1. How big is the global Erdafitinib Tablets market?
2. What is the demand of the global Erdafitinib Tablets market?
3. What is the year over year growth of the global Erdafitinib Tablets market?
4. What is the production and production value of the global Erdafitinib Tablets market?
5. Who are the key producers in the global Erdafitinib Tablets market?
6. What are the growth factors driving the market demand?
Erdafitinib is an oral, highly selective small?molecule pan?FGFR inhibitor that mainly targets fibroblast growth factor receptors FGFR1–4. It inhibits the activity of receptor tyrosine kinases and blocks downstream signal transduction, thereby suppressing tumor cell proliferation, differentiation and angiogenesis. As the world’s first approved FGFR?targeted drug for solid tumors, this agent is mainly indicated for advanced malignant tumors with FGFR genetic abnormalities, particularly for locally advanced or metastatic urothelial carcinoma after failure of platinum?based chemotherapy. It has important clinical value in the precision therapy of solid tumors such as bladder cancer and cholangiocarcinoma, providing a novel targeted therapeutic option for patients with FGFR?mutant tumors.n 2025, global Erdafitinib production reached approximately 42,000 units.
As the world’s first approved pan-FGFR inhibitor, Erdafitinib occupies a core position in the precision treatment of FGFR-mutant solid tumors. Its market pattern is characterized by dominance of the innovator drug, impact from generic drugs, and growth driven by medical insurance coverage and indication expansion. As a product of Johnson & Johnson, the drug has established a first-mover advantage owing to its significant efficacy in urothelial carcinoma, while indications are rapidly expanding to more FGFR-mutant cancers such as cholangiocarcinoma and lung cancer.
The domestic market was approved in early 2025; it has not yet been included in medical insurance, resulting in high prices and limited patient accessibility. Overseas generic versions (from Laos, Bangladesh) divert part of the demand at lower prices, intensifying market competition. Globally, Erdafitinib faces competition from other FGFR inhibitors including pemigatinib and infigratinib. Market competition is gradually shifting from single indications to multi-cancer applications and combination therapies.
In the future, with the advancement of medical insurance coverage, full launch of generic drugs, expanded indications, and clinical breakthroughs in combination with immunotherapy or anti-angiogenic therapy, the market for Erdafitinib will continue to expand. Meanwhile, the pricing system will become more rational and patient accessibility will be significantly improved.
This report studies the global Erdafitinib Tablets production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Erdafitinib Tablets and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Erdafitinib Tablets that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Erdafitinib Tablets total production and demand, 2021-2032, (Units)
Global Erdafitinib Tablets total production value, 2021-2032, (USD Million)
Global Erdafitinib Tablets production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Erdafitinib Tablets consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Erdafitinib Tablets domestic production, consumption, key domestic manufacturers and share
Global Erdafitinib Tablets production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Erdafitinib Tablets production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Erdafitinib Tablets production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Erdafitinib Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Janssen Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Erdafitinib Tablets market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Erdafitinib Tablets Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 4mg
- 3mg
- Bottle
- Box
- Innovator
- Generic
- Hospital
- Retail
- Online
- Locally Advanced or Metastatic Urothelial Carcinoma with FGFR Abnormalities
- Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Mutation
- Other Solid Tumors with FGFR Genetic Aberrations
- Janssen Pharmaceuticals
1. How big is the global Erdafitinib Tablets market?
2. What is the demand of the global Erdafitinib Tablets market?
3. What is the year over year growth of the global Erdafitinib Tablets market?
4. What is the production and production value of the global Erdafitinib Tablets market?
5. Who are the key producers in the global Erdafitinib Tablets market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Erdafitinib Tablets Introduction
1.2 World Erdafitinib Tablets Supply & Forecast
1.2.1 World Erdafitinib Tablets Production Value (2021 & 2025 & 2032)
1.2.2 World Erdafitinib Tablets Production (2021-2032)
1.2.3 World Erdafitinib Tablets Pricing Trends (2021-2032)
1.3 World Erdafitinib Tablets Production by Region (Based on Production Site)
1.3.1 World Erdafitinib Tablets Production Value by Region (2021-2032)
1.3.2 World Erdafitinib Tablets Production by Region (2021-2032)
1.3.3 World Erdafitinib Tablets Average Price by Region (2021-2032)
1.3.4 North America Erdafitinib Tablets Production (2021-2032)
1.3.5 Europe Erdafitinib Tablets Production (2021-2032)
1.3.6 China Erdafitinib Tablets Production (2021-2032)
1.3.7 Japan Erdafitinib Tablets Production (2021-2032)
1.3.8 India Erdafitinib Tablets Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Erdafitinib Tablets Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Erdafitinib Tablets Major Market Trends
2 DEMAND SUMMARY
2.1 World Erdafitinib Tablets Demand (2021-2032)
2.2 World Erdafitinib Tablets Consumption by Region
2.2.1 World Erdafitinib Tablets Consumption by Region (2021-2026)
2.2.2 World Erdafitinib Tablets Consumption Forecast by Region (2027-2032)
2.3 United States Erdafitinib Tablets Consumption (2021-2032)
2.4 China Erdafitinib Tablets Consumption (2021-2032)
2.5 Europe Erdafitinib Tablets Consumption (2021-2032)
2.6 Japan Erdafitinib Tablets Consumption (2021-2032)
2.7 South Korea Erdafitinib Tablets Consumption (2021-2032)
2.8 ASEAN Erdafitinib Tablets Consumption (2021-2032)
2.9 India Erdafitinib Tablets Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Erdafitinib Tablets Production Value by Manufacturer (2021-2026)
3.2 World Erdafitinib Tablets Production by Manufacturer (2021-2026)
3.3 World Erdafitinib Tablets Average Price by Manufacturer (2021-2026)
3.4 Erdafitinib Tablets Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Erdafitinib Tablets Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Erdafitinib Tablets in 2025
3.5.3 Global Concentration Ratios (CR8) for Erdafitinib Tablets in 2025
3.6 Erdafitinib Tablets Market: Overall Company Footprint Analysis
3.6.1 Erdafitinib Tablets Market: Region Footprint
3.6.2 Erdafitinib Tablets Market: Company Product Type Footprint
3.6.3 Erdafitinib Tablets Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Erdafitinib Tablets Production Value Comparison
4.1.1 United States VS China: Erdafitinib Tablets Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Erdafitinib Tablets Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Erdafitinib Tablets Production Comparison
4.2.1 United States VS China: Erdafitinib Tablets Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Erdafitinib Tablets Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Erdafitinib Tablets Consumption Comparison
4.3.1 United States VS China: Erdafitinib Tablets Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Erdafitinib Tablets Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Erdafitinib Tablets Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Erdafitinib Tablets Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Erdafitinib Tablets Production Value (2021-2026)
4.4.3 United States Based Manufacturers Erdafitinib Tablets Production (2021-2026)
4.5 China Based Erdafitinib Tablets Manufacturers and Market Share
4.5.1 China Based Erdafitinib Tablets Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Erdafitinib Tablets Production Value (2021-2026)
4.5.3 China Based Manufacturers Erdafitinib Tablets Production (2021-2026)
4.6 Rest of World Based Erdafitinib Tablets Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Erdafitinib Tablets Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Erdafitinib Tablets Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Erdafitinib Tablets Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Erdafitinib Tablets Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 4mg
5.2.2 3mg
5.3 Market Segment by Type
5.3.1 World Erdafitinib Tablets Production by Type (2021-2032)
5.3.2 World Erdafitinib Tablets Production Value by Type (2021-2032)
5.3.3 World Erdafitinib Tablets Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PACKAGING
6.1 World Erdafitinib Tablets Market Size Overview by Packaging: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Packaging
6.2.1 Bottle
6.2.2 Box
6.3 Market Segment by Packaging
6.3.1 World Erdafitinib Tablets Production by Packaging (2021-2032)
6.3.2 World Erdafitinib Tablets Production Value by Packaging (2021-2032)
6.3.3 World Erdafitinib Tablets Average Price by Packaging (2021-2032)
7 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
7.1 World Erdafitinib Tablets Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Technology
7.2.1 Innovator
7.2.2 Generic
7.3 Market Segment by Production Technology
7.3.1 World Erdafitinib Tablets Production by Production Technology (2021-2032)
7.3.2 World Erdafitinib Tablets Production Value by Production Technology (2021-2032)
7.3.3 World Erdafitinib Tablets Average Price by Production Technology (2021-2032)
8 MARKET ANALYSIS BY SALES CHANNEL
8.1 World Erdafitinib Tablets Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sales Channel
8.2.1 Hospital
8.2.2 Retail
8.2.3 Online
8.3 Market Segment by Sales Channel
8.3.1 World Erdafitinib Tablets Production by Sales Channel (2021-2032)
8.3.2 World Erdafitinib Tablets Production Value by Sales Channel (2021-2032)
8.3.3 World Erdafitinib Tablets Average Price by Sales Channel (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Erdafitinib Tablets Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Locally Advanced or Metastatic Urothelial Carcinoma with FGFR Abnormalities
9.2.2 Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Mutation
9.2.3 Other Solid Tumors with FGFR Genetic Aberrations
9.3 Market Segment by Application
9.3.1 World Erdafitinib Tablets Production by Application (2021-2032)
9.3.2 World Erdafitinib Tablets Production Value by Application (2021-2032)
9.3.3 World Erdafitinib Tablets Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Janssen Pharmaceuticals
10.1.1 Janssen Pharmaceuticals Details
10.1.2 Janssen Pharmaceuticals Major Business
10.1.3 Janssen Pharmaceuticals Erdafitinib Tablets Product and Services
10.1.4 Janssen Pharmaceuticals Erdafitinib Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Janssen Pharmaceuticals Recent Developments/Updates
10.1.6 Janssen Pharmaceuticals Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Erdafitinib Tablets Industry Chain
11.2 Erdafitinib Tablets Upstream Analysis
11.2.1 Erdafitinib Tablets Core Raw Materials
11.2.2 Main Manufacturers of Erdafitinib Tablets Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Erdafitinib Tablets Production Mode
11.6 Erdafitinib Tablets Procurement Model
11.7 Erdafitinib Tablets Industry Sales Model and Sales Channels
11.7.1 Erdafitinib Tablets Sales Model
11.7.2 Erdafitinib Tablets Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Erdafitinib Tablets Introduction
1.2 World Erdafitinib Tablets Supply & Forecast
1.2.1 World Erdafitinib Tablets Production Value (2021 & 2025 & 2032)
1.2.2 World Erdafitinib Tablets Production (2021-2032)
1.2.3 World Erdafitinib Tablets Pricing Trends (2021-2032)
1.3 World Erdafitinib Tablets Production by Region (Based on Production Site)
1.3.1 World Erdafitinib Tablets Production Value by Region (2021-2032)
1.3.2 World Erdafitinib Tablets Production by Region (2021-2032)
1.3.3 World Erdafitinib Tablets Average Price by Region (2021-2032)
1.3.4 North America Erdafitinib Tablets Production (2021-2032)
1.3.5 Europe Erdafitinib Tablets Production (2021-2032)
1.3.6 China Erdafitinib Tablets Production (2021-2032)
1.3.7 Japan Erdafitinib Tablets Production (2021-2032)
1.3.8 India Erdafitinib Tablets Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Erdafitinib Tablets Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Erdafitinib Tablets Major Market Trends
2 DEMAND SUMMARY
2.1 World Erdafitinib Tablets Demand (2021-2032)
2.2 World Erdafitinib Tablets Consumption by Region
2.2.1 World Erdafitinib Tablets Consumption by Region (2021-2026)
2.2.2 World Erdafitinib Tablets Consumption Forecast by Region (2027-2032)
2.3 United States Erdafitinib Tablets Consumption (2021-2032)
2.4 China Erdafitinib Tablets Consumption (2021-2032)
2.5 Europe Erdafitinib Tablets Consumption (2021-2032)
2.6 Japan Erdafitinib Tablets Consumption (2021-2032)
2.7 South Korea Erdafitinib Tablets Consumption (2021-2032)
2.8 ASEAN Erdafitinib Tablets Consumption (2021-2032)
2.9 India Erdafitinib Tablets Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Erdafitinib Tablets Production Value by Manufacturer (2021-2026)
3.2 World Erdafitinib Tablets Production by Manufacturer (2021-2026)
3.3 World Erdafitinib Tablets Average Price by Manufacturer (2021-2026)
3.4 Erdafitinib Tablets Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Erdafitinib Tablets Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Erdafitinib Tablets in 2025
3.5.3 Global Concentration Ratios (CR8) for Erdafitinib Tablets in 2025
3.6 Erdafitinib Tablets Market: Overall Company Footprint Analysis
3.6.1 Erdafitinib Tablets Market: Region Footprint
3.6.2 Erdafitinib Tablets Market: Company Product Type Footprint
3.6.3 Erdafitinib Tablets Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Erdafitinib Tablets Production Value Comparison
4.1.1 United States VS China: Erdafitinib Tablets Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Erdafitinib Tablets Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Erdafitinib Tablets Production Comparison
4.2.1 United States VS China: Erdafitinib Tablets Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Erdafitinib Tablets Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Erdafitinib Tablets Consumption Comparison
4.3.1 United States VS China: Erdafitinib Tablets Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Erdafitinib Tablets Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Erdafitinib Tablets Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Erdafitinib Tablets Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Erdafitinib Tablets Production Value (2021-2026)
4.4.3 United States Based Manufacturers Erdafitinib Tablets Production (2021-2026)
4.5 China Based Erdafitinib Tablets Manufacturers and Market Share
4.5.1 China Based Erdafitinib Tablets Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Erdafitinib Tablets Production Value (2021-2026)
4.5.3 China Based Manufacturers Erdafitinib Tablets Production (2021-2026)
4.6 Rest of World Based Erdafitinib Tablets Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Erdafitinib Tablets Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Erdafitinib Tablets Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Erdafitinib Tablets Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Erdafitinib Tablets Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 4mg
5.2.2 3mg
5.3 Market Segment by Type
5.3.1 World Erdafitinib Tablets Production by Type (2021-2032)
5.3.2 World Erdafitinib Tablets Production Value by Type (2021-2032)
5.3.3 World Erdafitinib Tablets Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PACKAGING
6.1 World Erdafitinib Tablets Market Size Overview by Packaging: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Packaging
6.2.1 Bottle
6.2.2 Box
6.3 Market Segment by Packaging
6.3.1 World Erdafitinib Tablets Production by Packaging (2021-2032)
6.3.2 World Erdafitinib Tablets Production Value by Packaging (2021-2032)
6.3.3 World Erdafitinib Tablets Average Price by Packaging (2021-2032)
7 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
7.1 World Erdafitinib Tablets Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Technology
7.2.1 Innovator
7.2.2 Generic
7.3 Market Segment by Production Technology
7.3.1 World Erdafitinib Tablets Production by Production Technology (2021-2032)
7.3.2 World Erdafitinib Tablets Production Value by Production Technology (2021-2032)
7.3.3 World Erdafitinib Tablets Average Price by Production Technology (2021-2032)
8 MARKET ANALYSIS BY SALES CHANNEL
8.1 World Erdafitinib Tablets Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sales Channel
8.2.1 Hospital
8.2.2 Retail
8.2.3 Online
8.3 Market Segment by Sales Channel
8.3.1 World Erdafitinib Tablets Production by Sales Channel (2021-2032)
8.3.2 World Erdafitinib Tablets Production Value by Sales Channel (2021-2032)
8.3.3 World Erdafitinib Tablets Average Price by Sales Channel (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Erdafitinib Tablets Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Locally Advanced or Metastatic Urothelial Carcinoma with FGFR Abnormalities
9.2.2 Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Mutation
9.2.3 Other Solid Tumors with FGFR Genetic Aberrations
9.3 Market Segment by Application
9.3.1 World Erdafitinib Tablets Production by Application (2021-2032)
9.3.2 World Erdafitinib Tablets Production Value by Application (2021-2032)
9.3.3 World Erdafitinib Tablets Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Janssen Pharmaceuticals
10.1.1 Janssen Pharmaceuticals Details
10.1.2 Janssen Pharmaceuticals Major Business
10.1.3 Janssen Pharmaceuticals Erdafitinib Tablets Product and Services
10.1.4 Janssen Pharmaceuticals Erdafitinib Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Janssen Pharmaceuticals Recent Developments/Updates
10.1.6 Janssen Pharmaceuticals Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Erdafitinib Tablets Industry Chain
11.2 Erdafitinib Tablets Upstream Analysis
11.2.1 Erdafitinib Tablets Core Raw Materials
11.2.2 Main Manufacturers of Erdafitinib Tablets Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Erdafitinib Tablets Production Mode
11.6 Erdafitinib Tablets Procurement Model
11.7 Erdafitinib Tablets Industry Sales Model and Sales Channels
11.7.1 Erdafitinib Tablets Sales Model
11.7.2 Erdafitinib Tablets Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World ErdafitinibTablets Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World ErdafitinibTablets Production Value by Region (2021-2026) & (USD Million)
Table 3. World ErdafitinibTablets Production Value by Region (2027-2032) & (USD Million)
Table 4. World ErdafitinibTablets Production Value Market Share by Region (2021-2026)
Table 5. World ErdafitinibTablets Production Value Market Share by Region (2027-2032)
Table 6. World ErdafitinibTablets Production by Region (2021-2026) & (Units)
Table 7. World ErdafitinibTablets Production by Region (2027-2032) & (Units)
Table 8. World ErdafitinibTablets Production Market Share by Region (2021-2026)
Table 9. World ErdafitinibTablets Production Market Share by Region (2027-2032)
Table 10. World ErdafitinibTablets Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World ErdafitinibTablets Average Price by Region (2027-2032) & (US$/Unit)
Table 12. ErdafitinibTablets Major Market Trends
Table 13. World ErdafitinibTablets Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World ErdafitinibTablets Consumption by Region (2021-2026) & (Units)
Table 15. World ErdafitinibTablets Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World ErdafitinibTablets Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key ErdafitinibTablets Producers in 2025
Table 18. World ErdafitinibTablets Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key ErdafitinibTablets Producers in 2025
Table 20. World ErdafitinibTablets Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global ErdafitinibTablets Company Evaluation Quadrant
Table 22. World ErdafitinibTablets Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and ErdafitinibTablets Production Site of Key Manufacturer
Table 24. ErdafitinibTablets Market: Company Product Type Footprint
Table 25. ErdafitinibTablets Market: Company Product Application Footprint
Table 26. ErdafitinibTablets Competitive Factors
Table 27. ErdafitinibTablets New Entrant and Capacity Expansion Plans
Table 28. ErdafitinibTablets Mergers & Acquisitions Activity
Table 29. United States VS China ErdafitinibTablets Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China ErdafitinibTablets Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China ErdafitinibTablets Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based ErdafitinibTablets Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers ErdafitinibTablets Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers ErdafitinibTablets Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers ErdafitinibTablets Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers ErdafitinibTablets Production Market Share (2021-2026)
Table 37. China Based ErdafitinibTablets Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers ErdafitinibTablets Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers ErdafitinibTablets Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers ErdafitinibTablets Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers ErdafitinibTablets Production Market Share (2021-2026)
Table 42. Rest of World Based ErdafitinibTablets Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers ErdafitinibTablets Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers ErdafitinibTablets Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers ErdafitinibTablets Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers ErdafitinibTablets Production Market Share (2021-2026)
Table 47. World ErdafitinibTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World ErdafitinibTablets Production by Type (2021-2026) & (Units)
Table 49. World ErdafitinibTablets Production by Type (2027-2032) & (Units)
Table 50. World ErdafitinibTablets Production Value by Type (2021-2026) & (USD Million)
Table 51. World ErdafitinibTablets Production Value by Type (2027-2032) & (USD Million)
Table 52. World ErdafitinibTablets Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World ErdafitinibTablets Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World ErdafitinibTablets Production Value by Packaging, (USD Million), 2021 & 2025 & 2032
Table 55. World ErdafitinibTablets Production by Packaging (2021-2026) & (Units)
Table 56. World ErdafitinibTablets Production by Packaging (2027-2032) & (Units)
Table 57. World ErdafitinibTablets Production Value by Packaging (2021-2026) & (USD Million)
Table 58. World ErdafitinibTablets Production Value by Packaging (2027-2032) & (USD Million)
Table 59. World ErdafitinibTablets Average Price by Packaging (2021-2026) & (US$/Unit)
Table 60. World ErdafitinibTablets Average Price by Packaging (2027-2032) & (US$/Unit)
Table 61. World ErdafitinibTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 62. World ErdafitinibTablets Production by Production Technology (2021-2026) & (Units)
Table 63. World ErdafitinibTablets Production by Production Technology (2027-2032) & (Units)
Table 64. World ErdafitinibTablets Production Value by Production Technology (2021-2026) & (USD Million)
Table 65. World ErdafitinibTablets Production Value by Production Technology (2027-2032) & (USD Million)
Table 66. World ErdafitinibTablets Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 67. World ErdafitinibTablets Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 68. World ErdafitinibTablets Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 69. World ErdafitinibTablets Production by Sales Channel (2021-2026) & (Units)
Table 70. World ErdafitinibTablets Production by Sales Channel (2027-2032) & (Units)
Table 71. World ErdafitinibTablets Production Value by Sales Channel (2021-2026) & (USD Million)
Table 72. World ErdafitinibTablets Production Value by Sales Channel (2027-2032) & (USD Million)
Table 73. World ErdafitinibTablets Average Price by Sales Channel (2021-2026) & (US$/Unit)
Table 74. World ErdafitinibTablets Average Price by Sales Channel (2027-2032) & (US$/Unit)
Table 75. World ErdafitinibTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World ErdafitinibTablets Production by Application (2021-2026) & (Units)
Table 77. World ErdafitinibTablets Production by Application (2027-2032) & (Units)
Table 78. World ErdafitinibTablets Production Value by Application (2021-2026) & (USD Million)
Table 79. World ErdafitinibTablets Production Value by Application (2027-2032) & (USD Million)
Table 80. World ErdafitinibTablets Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World ErdafitinibTablets Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 83. Janssen Pharmaceuticals Major Business
Table 84. Janssen Pharmaceuticals ErdafitinibTablets Product and Services
Table 85. Janssen Pharmaceuticals ErdafitinibTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Janssen Pharmaceuticals Recent Developments/Updates
Table 87. Janssen Pharmaceuticals Competitive Strengths & Weaknesses
Table 88. Global Key Players of ErdafitinibTablets Upstream (Raw Materials)
Table 89. Global ErdafitinibTablets Typical Customers
Table 90. ErdafitinibTablets Typical Distributors
Table 1. World ErdafitinibTablets Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World ErdafitinibTablets Production Value by Region (2021-2026) & (USD Million)
Table 3. World ErdafitinibTablets Production Value by Region (2027-2032) & (USD Million)
Table 4. World ErdafitinibTablets Production Value Market Share by Region (2021-2026)
Table 5. World ErdafitinibTablets Production Value Market Share by Region (2027-2032)
Table 6. World ErdafitinibTablets Production by Region (2021-2026) & (Units)
Table 7. World ErdafitinibTablets Production by Region (2027-2032) & (Units)
Table 8. World ErdafitinibTablets Production Market Share by Region (2021-2026)
Table 9. World ErdafitinibTablets Production Market Share by Region (2027-2032)
Table 10. World ErdafitinibTablets Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World ErdafitinibTablets Average Price by Region (2027-2032) & (US$/Unit)
Table 12. ErdafitinibTablets Major Market Trends
Table 13. World ErdafitinibTablets Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World ErdafitinibTablets Consumption by Region (2021-2026) & (Units)
Table 15. World ErdafitinibTablets Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World ErdafitinibTablets Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key ErdafitinibTablets Producers in 2025
Table 18. World ErdafitinibTablets Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key ErdafitinibTablets Producers in 2025
Table 20. World ErdafitinibTablets Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global ErdafitinibTablets Company Evaluation Quadrant
Table 22. World ErdafitinibTablets Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and ErdafitinibTablets Production Site of Key Manufacturer
Table 24. ErdafitinibTablets Market: Company Product Type Footprint
Table 25. ErdafitinibTablets Market: Company Product Application Footprint
Table 26. ErdafitinibTablets Competitive Factors
Table 27. ErdafitinibTablets New Entrant and Capacity Expansion Plans
Table 28. ErdafitinibTablets Mergers & Acquisitions Activity
Table 29. United States VS China ErdafitinibTablets Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China ErdafitinibTablets Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China ErdafitinibTablets Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based ErdafitinibTablets Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers ErdafitinibTablets Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers ErdafitinibTablets Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers ErdafitinibTablets Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers ErdafitinibTablets Production Market Share (2021-2026)
Table 37. China Based ErdafitinibTablets Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers ErdafitinibTablets Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers ErdafitinibTablets Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers ErdafitinibTablets Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers ErdafitinibTablets Production Market Share (2021-2026)
Table 42. Rest of World Based ErdafitinibTablets Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers ErdafitinibTablets Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers ErdafitinibTablets Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers ErdafitinibTablets Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers ErdafitinibTablets Production Market Share (2021-2026)
Table 47. World ErdafitinibTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World ErdafitinibTablets Production by Type (2021-2026) & (Units)
Table 49. World ErdafitinibTablets Production by Type (2027-2032) & (Units)
Table 50. World ErdafitinibTablets Production Value by Type (2021-2026) & (USD Million)
Table 51. World ErdafitinibTablets Production Value by Type (2027-2032) & (USD Million)
Table 52. World ErdafitinibTablets Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World ErdafitinibTablets Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World ErdafitinibTablets Production Value by Packaging, (USD Million), 2021 & 2025 & 2032
Table 55. World ErdafitinibTablets Production by Packaging (2021-2026) & (Units)
Table 56. World ErdafitinibTablets Production by Packaging (2027-2032) & (Units)
Table 57. World ErdafitinibTablets Production Value by Packaging (2021-2026) & (USD Million)
Table 58. World ErdafitinibTablets Production Value by Packaging (2027-2032) & (USD Million)
Table 59. World ErdafitinibTablets Average Price by Packaging (2021-2026) & (US$/Unit)
Table 60. World ErdafitinibTablets Average Price by Packaging (2027-2032) & (US$/Unit)
Table 61. World ErdafitinibTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 62. World ErdafitinibTablets Production by Production Technology (2021-2026) & (Units)
Table 63. World ErdafitinibTablets Production by Production Technology (2027-2032) & (Units)
Table 64. World ErdafitinibTablets Production Value by Production Technology (2021-2026) & (USD Million)
Table 65. World ErdafitinibTablets Production Value by Production Technology (2027-2032) & (USD Million)
Table 66. World ErdafitinibTablets Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 67. World ErdafitinibTablets Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 68. World ErdafitinibTablets Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 69. World ErdafitinibTablets Production by Sales Channel (2021-2026) & (Units)
Table 70. World ErdafitinibTablets Production by Sales Channel (2027-2032) & (Units)
Table 71. World ErdafitinibTablets Production Value by Sales Channel (2021-2026) & (USD Million)
Table 72. World ErdafitinibTablets Production Value by Sales Channel (2027-2032) & (USD Million)
Table 73. World ErdafitinibTablets Average Price by Sales Channel (2021-2026) & (US$/Unit)
Table 74. World ErdafitinibTablets Average Price by Sales Channel (2027-2032) & (US$/Unit)
Table 75. World ErdafitinibTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World ErdafitinibTablets Production by Application (2021-2026) & (Units)
Table 77. World ErdafitinibTablets Production by Application (2027-2032) & (Units)
Table 78. World ErdafitinibTablets Production Value by Application (2021-2026) & (USD Million)
Table 79. World ErdafitinibTablets Production Value by Application (2027-2032) & (USD Million)
Table 80. World ErdafitinibTablets Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World ErdafitinibTablets Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 83. Janssen Pharmaceuticals Major Business
Table 84. Janssen Pharmaceuticals ErdafitinibTablets Product and Services
Table 85. Janssen Pharmaceuticals ErdafitinibTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Janssen Pharmaceuticals Recent Developments/Updates
Table 87. Janssen Pharmaceuticals Competitive Strengths & Weaknesses
Table 88. Global Key Players of ErdafitinibTablets Upstream (Raw Materials)
Table 89. Global ErdafitinibTablets Typical Customers
Table 90. ErdafitinibTablets Typical Distributors
LIST OF FIGURES
Figure 1. ErdafitinibTablets Picture
Figure 2. World ErdafitinibTablets Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World ErdafitinibTablets Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World ErdafitinibTablets Production (2021-2032) & (Units)
Figure 5. World ErdafitinibTablets Average Price (2021-2032) & (US$/Unit)
Figure 6. World ErdafitinibTablets Production Value Market Share by Region (2021-2032)
Figure 7. World ErdafitinibTablets Production Market Share by Region (2021-2032)
Figure 8. North America ErdafitinibTablets Production (2021-2032) & (Units)
Figure 9. Europe ErdafitinibTablets Production (2021-2032) & (Units)
Figure 10. China ErdafitinibTablets Production (2021-2032) & (Units)
Figure 11. Japan ErdafitinibTablets Production (2021-2032) & (Units)
Figure 12. India ErdafitinibTablets Production (2021-2032) & (Units)
Figure 13. ErdafitinibTablets Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 16. World ErdafitinibTablets Consumption Market Share by Region (2021-2032)
Figure 17. United States ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 18. China ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 19. Europe ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 20. Japan ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 21. South Korea ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 22. ASEAN ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 23. India ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of ErdafitinibTablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for ErdafitinibTablets Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for ErdafitinibTablets Markets in 2025
Figure 27. United States VS China: ErdafitinibTablets Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: ErdafitinibTablets Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: ErdafitinibTablets Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers ErdafitinibTablets Production Market Share 2025
Figure 31. China Based Manufacturers ErdafitinibTablets Production Market Share 2025
Figure 32. Rest of World Based Manufacturers ErdafitinibTablets Production Market Share 2025
Figure 33. World ErdafitinibTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World ErdafitinibTablets Production Value Market Share by Type in 2025
Figure 35. 4mg
Figure 36. 3mg
Figure 37. World ErdafitinibTablets Production Market Share by Type (2021-2032)
Figure 38. World ErdafitinibTablets Production Value Market Share by Type (2021-2032)
Figure 39. World ErdafitinibTablets Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World ErdafitinibTablets Production Value by Packaging, (USD Million), 2021 & 2025 & 2032
Figure 41. World ErdafitinibTablets Production Value Market Share by Packaging in 2025
Figure 42. Bottle
Figure 43. Box
Figure 44. World ErdafitinibTablets Production Market Share by Packaging (2021-2032)
Figure 45. World ErdafitinibTablets Production Value Market Share by Packaging (2021-2032)
Figure 46. World ErdafitinibTablets Average Price by Packaging (2021-2032) & (US$/Unit)
Figure 47. World ErdafitinibTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 48. World ErdafitinibTablets Production Value Market Share by Production Technology in 2025
Figure 49. Innovator
Figure 50. Generic
Figure 51. World ErdafitinibTablets Production Market Share by Production Technology (2021-2032)
Figure 52. World ErdafitinibTablets Production Value Market Share by Production Technology (2021-2032)
Figure 53. World ErdafitinibTablets Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 54. World ErdafitinibTablets Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 55. World ErdafitinibTablets Production Value Market Share by Sales Channel in 2025
Figure 56. Hospital
Figure 57. Retail
Figure 58. Online
Figure 59. World ErdafitinibTablets Production Market Share by Sales Channel (2021-2032)
Figure 60. World ErdafitinibTablets Production Value Market Share by Sales Channel (2021-2032)
Figure 61. World ErdafitinibTablets Average Price by Sales Channel (2021-2032) & (US$/Unit)
Figure 62. World ErdafitinibTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World ErdafitinibTablets Production Value Market Share by Application in 2025
Figure 64. Locally Advanced or Metastatic Urothelial Carcinoma with FGFR Abnormalities
Figure 65. Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Mutation
Figure 66. Other Solid Tumors with FGFR Genetic Aberrations
Figure 67. World ErdafitinibTablets Production Market Share by Application (2021-2032)
Figure 68. World ErdafitinibTablets Production Value Market Share by Application (2021-2032)
Figure 69. World ErdafitinibTablets Average Price by Application (2021-2032) & (US$/Unit)
Figure 70. ErdafitinibTablets Industry Chain
Figure 71. ErdafitinibTablets Procurement Model
Figure 72. ErdafitinibTablets Sales Model
Figure 73. ErdafitinibTablets Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. ErdafitinibTablets Picture
Figure 2. World ErdafitinibTablets Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World ErdafitinibTablets Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World ErdafitinibTablets Production (2021-2032) & (Units)
Figure 5. World ErdafitinibTablets Average Price (2021-2032) & (US$/Unit)
Figure 6. World ErdafitinibTablets Production Value Market Share by Region (2021-2032)
Figure 7. World ErdafitinibTablets Production Market Share by Region (2021-2032)
Figure 8. North America ErdafitinibTablets Production (2021-2032) & (Units)
Figure 9. Europe ErdafitinibTablets Production (2021-2032) & (Units)
Figure 10. China ErdafitinibTablets Production (2021-2032) & (Units)
Figure 11. Japan ErdafitinibTablets Production (2021-2032) & (Units)
Figure 12. India ErdafitinibTablets Production (2021-2032) & (Units)
Figure 13. ErdafitinibTablets Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 16. World ErdafitinibTablets Consumption Market Share by Region (2021-2032)
Figure 17. United States ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 18. China ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 19. Europe ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 20. Japan ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 21. South Korea ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 22. ASEAN ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 23. India ErdafitinibTablets Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of ErdafitinibTablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for ErdafitinibTablets Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for ErdafitinibTablets Markets in 2025
Figure 27. United States VS China: ErdafitinibTablets Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: ErdafitinibTablets Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: ErdafitinibTablets Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers ErdafitinibTablets Production Market Share 2025
Figure 31. China Based Manufacturers ErdafitinibTablets Production Market Share 2025
Figure 32. Rest of World Based Manufacturers ErdafitinibTablets Production Market Share 2025
Figure 33. World ErdafitinibTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World ErdafitinibTablets Production Value Market Share by Type in 2025
Figure 35. 4mg
Figure 36. 3mg
Figure 37. World ErdafitinibTablets Production Market Share by Type (2021-2032)
Figure 38. World ErdafitinibTablets Production Value Market Share by Type (2021-2032)
Figure 39. World ErdafitinibTablets Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World ErdafitinibTablets Production Value by Packaging, (USD Million), 2021 & 2025 & 2032
Figure 41. World ErdafitinibTablets Production Value Market Share by Packaging in 2025
Figure 42. Bottle
Figure 43. Box
Figure 44. World ErdafitinibTablets Production Market Share by Packaging (2021-2032)
Figure 45. World ErdafitinibTablets Production Value Market Share by Packaging (2021-2032)
Figure 46. World ErdafitinibTablets Average Price by Packaging (2021-2032) & (US$/Unit)
Figure 47. World ErdafitinibTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 48. World ErdafitinibTablets Production Value Market Share by Production Technology in 2025
Figure 49. Innovator
Figure 50. Generic
Figure 51. World ErdafitinibTablets Production Market Share by Production Technology (2021-2032)
Figure 52. World ErdafitinibTablets Production Value Market Share by Production Technology (2021-2032)
Figure 53. World ErdafitinibTablets Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 54. World ErdafitinibTablets Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 55. World ErdafitinibTablets Production Value Market Share by Sales Channel in 2025
Figure 56. Hospital
Figure 57. Retail
Figure 58. Online
Figure 59. World ErdafitinibTablets Production Market Share by Sales Channel (2021-2032)
Figure 60. World ErdafitinibTablets Production Value Market Share by Sales Channel (2021-2032)
Figure 61. World ErdafitinibTablets Average Price by Sales Channel (2021-2032) & (US$/Unit)
Figure 62. World ErdafitinibTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World ErdafitinibTablets Production Value Market Share by Application in 2025
Figure 64. Locally Advanced or Metastatic Urothelial Carcinoma with FGFR Abnormalities
Figure 65. Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Mutation
Figure 66. Other Solid Tumors with FGFR Genetic Aberrations
Figure 67. World ErdafitinibTablets Production Market Share by Application (2021-2032)
Figure 68. World ErdafitinibTablets Production Value Market Share by Application (2021-2032)
Figure 69. World ErdafitinibTablets Average Price by Application (2021-2032) & (US$/Unit)
Figure 70. ErdafitinibTablets Industry Chain
Figure 71. ErdafitinibTablets Procurement Model
Figure 72. ErdafitinibTablets Sales Model
Figure 73. ErdafitinibTablets Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
